Xpert MTB/RIF performance to diagnose tuberculosis and rifampicin resistance in a reference centre in southern Brazil
Effective treatment of tuberculosis (TB) remains a serious public health problem in many countries, including Brazil, especially when considering drug-resistant disease. Xpert MTB/RIF has been implemented in many countries to reduce the time to TB diagnosis and to rapidly detect rifampicin resistanc...
Main Authors: | Cinara Silva Feliciano, Lucas José Bazzo Menon, Livia Maria Pala Anselmo, Anzaan Dippenaar, Robin Mark Warren, Wilson Araújo Silva, Valdes Roberto Bollela |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2019-08-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/5/3/00043-2019.full |
Similar Items
-
Management of false-positive rifampicin resistant Xpert MTB/RIF
by: Natalie Beylis, et al.
Published: (2020-10-01) -
An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF
by: Yeliz Tanriverdi Cayci, et al. -
Management of falsepositive rifampicin resistant Xpert MTB/RIF – Authors' reply
by: Jean Claude Semuto Ngabonziza, et al.
Published: (2020-10-01) -
Xpert MTB/RIF assay for the diagnosis of rifampicin resistance in different regions: a meta-analysis
by: Kaican Zong, et al.
Published: (2019-08-01) -
Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
by: Zheyuan Wu, et al.
Published: (2020-02-01)